Oral nano‐curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease ‐19 patients: An open label nonrandomized clinical trial
Niloofar Saber‐moghaddam, Soofia Salari, Sepideh Hejazi, Mahnaz Amini, Zhila Taherzadeh, Saeed Eslami, Seyed Mahdi Rezayat, Mahmoud Reza Jaafari, Sepideh Elyasi
Phytotherapy Research, doi:10.1002/ptr.7004
Curcumin is proposed as a potential treatment option for coronavirus disease-19 by inhibiting the virus entrance, encapsulation and replication, and modulating various cellular signaling pathways. In this open-label nonrandomized clinical trial, efficacy of nano-curcumin oral formulation has been evaluated in hospitalized patients with mild-moderate COVID-19. Forty-one patients who fulfilled the inclusion criteria were allocated to nano-curcumin (n = 21) group (Sinacurcumin soft gel, contains 40 mg curcuminoids as nanomicelles, two capsules twice a day) or control (n = 20) group, for 2 weeks. Patients' symptoms and laboratory data were assessed at baseline and during follow-up period. Most of symptoms including fever and chills, tachypnea, myalgia, and cough resolved significantly faster in curcumin group. Moreover, SaO 2 was significantly higher in treatment group after 2, 4, 7, and 14 days of follow-up and lymphocyte count after 7 and 14 days. Duration of supplemental O 2 use and hospitalization was also meaningfully shorter in treatment group. It is also noteworthy to mention that no patient in treatment group experienced deterioration of infection during follow-up period, but it occurred in 40% of control group. Oral curcumin nano-formulation can significantly improve recovery time in hospitalized COVID-19 patients. Further randomized placebo controlled trials with larger sample size are recommended.
References
Abdollahi, Momtazi, Johnston, Sahebkar, Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?, Journal of Cellular Physiology,
doi:10.1002/jcp.25778Akbari, Kariznavi, Jannati, Elyasi, Tayarani-Najaran, Curcumin as a preventive or therapeutic measure for chemotherapy and radiotherapy induced adverse reaction: A comprehensive review, Food and Chemical Toxicology,
doi:10.1016/j.fct.2020.111699Avasarala, Zhang, Liu, Wang, London et al., Correction: Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome, PLoS One,
doi:10.1371/journal.pone.0057285Avasarala, Zhang, Liu, Wang, London et al., Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome, PLoS One,
doi:10.1371/journal.pone.0057285Biswas, Mcclure, Jimenez, Megson, Rahman, Curcumin induces glutathione biosynthesis and inhibits NF-κB activation and interleukin-8 release in alveolar epithelial cells: Mechanism of free radical scavenging activity, Antioxidants & Redox Signaling,
doi:10.1089/ars.2005.7.32Castro Rocha, Renato De Assis, Curcumin as a potential treatment for COVID-19, Phytotherapy Research,
doi:10.1002/ptr.6745Gupta, Patchva, Koh, Aggarwal, Discovery of curcumin, a component of golden spice, and its miraculous biological activities, Clinical and Experimental Pharmacology and Physiology,
doi:10.1111/j.1440-1681.2011.05648.xHatamipour, Sahebkar, Alavizadeh, Dorri, Jaafari, Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids, Iranian Journal of Basic Medical Sciences,
doi:10.22038/ijbms.2019.32873.7852Jain, Rains, Croad, Larson, Jones, Curcumin supplementation lowers TNF-α, IL-6, IL-8, and MCP-1 secretion in high glucosetreated cultured monocytes and blood levels of TNF-α, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats, Antioxidants & Redox Signaling,
doi:10.1089/ars.2008.2140Jäger, Lowery, Calvanese, Joy, Purpura et al., Comparative absorption of curcumin formulations, Nutrition Journal,
doi:10.1186/1475-2891-13-11Kloesch, Becker, Dietersdorfer, Kiener, Steiner, Anti-inflammatory and apoptotic effects of the polyphenol curcumin on human fibroblast-like synoviocytes, International Immunopharmacology,
doi:10.1016/j.intimp.2013.01.003Kulkarni, Kumar, Tevethia, Premkumar, Arab et al., Systematic review with meta-analysis: Liver manifestations and outcomes in COVID-19, Alimentary Pharmacology & Therapeutics,
doi:10.1111/apt.15916Kumar-M, Mishra, Jha, Shukla, Choudhury et al., Coronavirus disease (COVID-19) and the liver: A comprehensive systematic review and meta-analysis, Hepatology International,
doi:10.1007/s12072-020-10071-9Moballegh Naseri, Abadi, Poormoghadam, Zarrabi, Keyhanvar et al., Curcumin delivery mediated by bio-Based nanoparticles, A Review. Molecules
Moghadamtousi, Abdul Kadir, Hassandarvish, Tajik, Abubakar et al., A review on antibacterial, antiviral, and antifungal activity of curcumin, BioMed Research International,
doi:10.1155/2014/186864Mollazadeh, Cicero, Blesso, Pirro, Majeed et al., Immune modulation by curcumin: The role of interleukin-10, Critical Reviews in Food Science and Nutrition,
doi:10.1080/10408398.2017.1358139Mounce, Cesaro, Carrau, Vallet, Vignuzzi, Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding, Antiviral Research,
doi:10.1016/j.antiviral.2017.03.014Nelson, Dahlin, Bisson, Graham, Pauli et al., The essential medicinal chemistry of curcumin, Journal of Medicinal Chemistry
Noor, Islam, Prevalence and associated risk factors of mortality among COVID-19 patients: A meta-analysis, Journal of Community Health,
doi:10.1007/s10900-020-00920-xPraditya, Kirchhoff, Brüning, Rachmawati, Steinmann et al., Anti-infective properties of the golden spice curcumin, Frontiers in Microbiology
Prasad, Tyagi, Curcumin and its analogues: A potential natural compound against HIV infection and AIDS, Food & Function,
doi:10.1039/c5fo00485cRaflee, Nelson, Manley, Wellner, Floer et al., Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): Role of PKC, MAPKs, and NF-ĸB, American Journal of Physiology-Gastrointestinal and Liver Physiology,
doi:10.1152/ajpgi.90428.2008Richardson, Griffin, Tucker, Smith, Oechsle et al., Baricitinib as potential treatment for 2019-nCoV acute respiratory disease, Lancet,
doi:10.1016/S0140-6736(20)30304-4Rodriguez-Morales, Cardona-Ospina, Gutiérrez-Ocampo, Villamizar-Peña, Holguin-Rivera et al., Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis, Travel Medicine and Infectious Disease,
doi:10.1016/j.tmaid.2020.101623Roy, Sarkar, Celik, Ghosh, Basu et al., Can concomitant use of zinc and curcumin with other immunityboosting nutraceuticals be the arsenal against COVID-19?, Phytotherapy Research,
doi:10.1002/ptr.6766Ruan, Yang, Wang, Jiang, Song, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Medicine,
doi:10.1007/s00134-020-05991-xShakoory, Carcillo, Chatham, Amdur, Zhao et al., Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of the macrophage activation syndrome: Re-analysis of a prior Phase III trial, Critical Care Medicine,
doi:10.1097/CCM.0000000000001402Song, Ge, Cai, Zhang, Curcumin protects mice from coxsackievirus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/nuclear factor-κB pathway, Journal of Cardiovascular Pharmacology and Therapeutics,
doi:10.1177/1074248413503044Whitehead, Julious, Cooper, Campbell, Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable, Statistical Methods in Medical Research,
doi:10.1177/0962280215588241Zahedipour, Hosseini, Sathyapalan, Majeed, Jamialahmadi et al., Potential effects of curcumin in the treatment of COVID-19 infection, Phytotherapy Research,
doi:10.1002/ptr.6738{ 'indexed': {'date-parts': [[2024, 3, 23]], 'date-time': '2024-03-23T10:58:36Z', 'timestamp': 1711191516750},
'reference-count': 34,
'publisher': 'Wiley',
'issue': '5',
'license': [ { 'start': { 'date-parts': [[2021, 1, 3]],
'date-time': '2021-01-03T00:00:00Z',
'timestamp': 1609632000000},
'content-version': 'vor',
'delay-in-days': 0,
'URL': 'http://onlinelibrary.wiley.com/termsAndConditions#vor'}],
'content-domain': {'domain': ['onlinelibrary.wiley.com'], 'crossmark-restriction': True},
'published-print': {'date-parts': [[2021, 5]]},
'abstract': '<jats:p>Curcumin is proposed as a potential treatment option for coronavirus disease‐19 '
'(COVID‐19) by inhibiting the virus entrance, encapsulation and replication, and modulating '
'various cellular signaling pathways. In this open‐label nonrandomized clinical trial, '
'efficacy of nano‐curcumin oral formulation has been evaluated in hospitalized patients with '
'mild–moderate COVID‐19. Forty‐one patients who fulfilled the inclusion criteria were '
'allocated to nano‐curcumin (<jats:italic>n</jats:italic> = 21) group (Sinacurcumin soft gel, '
'contains 40\u2009mg curcuminoids as nanomicelles, two capsules twice a day) or control '
"(<jats:italic>n</jats:italic> = 20) group, for 2\u2009weeks. Patients' symptoms and "
'laboratory data were assessed at baseline and during follow‐up period. Most of symptoms '
'including fever and chills, tachypnea, myalgia, and cough resolved significantly faster in '
'curcumin group. Moreover, SaO<jats:sub>2</jats:sub> was significantly higher in treatment '
'group after 2, 4, 7, and 14\u2009days of follow‐up and lymphocyte count after 7 and 14\u2009'
'days. Duration of supplemental O<jats:sub>2</jats:sub> use and hospitalization was also '
'meaningfully shorter in treatment group. It is also noteworthy to mention that no patient in '
'treatment group experienced deterioration of infection during follow‐up period, but it '
'occurred in 40% of control group. Oral curcumin nano‐formulation can significantly improve '
'recovery time in hospitalized COVID‐19 patients. Further randomized placebo controlled trials '
'with larger sample size are recommended.</jats:p>',
'DOI': '10.1002/ptr.7004',
'type': 'journal-article',
'created': {'date-parts': [[2021, 1, 3]], 'date-time': '2021-01-03T23:05:08Z', 'timestamp': 1609715108000},
'page': '2616-2623',
'update-policy': 'http://dx.doi.org/10.1002/crossmark_policy',
'source': 'Crossref',
'is-referenced-by-count': 80,
'title': 'Oral nano‐curcumin formulation efficacy in management of mild to moderate hospitalized '
'<scp>coronavirus disease</scp>‐19 patients: An open label nonrandomized clinical trial',
'prefix': '10.1002',
'volume': '35',
'author': [ { 'given': 'Niloofar',
'family': 'Saber‐Moghaddam',
'sequence': 'first',
'affiliation': [ { 'name': 'Department of Clinical Pharmacy, School of Pharmacy Mashhad '
'University of Medical Sciences Mashhad Iran'}]},
{ 'given': 'Soofia',
'family': 'Salari',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Clinical Pharmacy, School of Pharmacy Mashhad '
'University of Medical Sciences Mashhad Iran'}]},
{ 'given': 'Sepideh',
'family': 'Hejazi',
'sequence': 'additional',
'affiliation': [ { 'name': 'Rheumatic Diseases Research Center, School of Medicine Mashhad '
'University of Medical Sciences Mashhad Iran'}]},
{ 'given': 'Mahnaz',
'family': 'Amini',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Internal Medicine Mashhad University of Medical '
'Sciences Mashhad Iran'}]},
{ 'ORCID': 'http://orcid.org/0000-0001-7185-970X',
'authenticated-orcid': False,
'given': 'Zhila',
'family': 'Taherzadeh',
'sequence': 'additional',
'affiliation': [ { 'name': 'Targeted Drug Delivery Research Center, School of Pharmacy '
'Mashhad University of Medical Sciences Mashhad Iran'}]},
{ 'given': 'Saeed',
'family': 'Eslami',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Medical Informatics, Faculty of Medicine Mashhad '
'University of Medical Sciences Mashhad Iran'}]},
{ 'given': 'Seyed Mahdi',
'family': 'Rezayat',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Pharmacology, School of Medicine Tehran University '
'of Medical Sciences Tehran Iran'}]},
{ 'given': 'Mahmoud Reza',
'family': 'Jaafari',
'sequence': 'additional',
'affiliation': [ { 'name': 'Nanotechnology Research Center Pharmaceutical Technology '
'Institute, Mashhad University of Medical Sciences Mashhad Iran'},
{ 'name': 'Department of Pharmaceutical Nanotechnology, School of Pharmacy '
'Mashhad University of Medical Sciences Mashhad Iran'}]},
{ 'ORCID': 'http://orcid.org/0000-0001-9857-1175',
'authenticated-orcid': False,
'given': 'Sepideh',
'family': 'Elyasi',
'sequence': 'additional',
'affiliation': [ { 'name': 'Department of Clinical Pharmacy, School of Pharmacy Mashhad '
'University of Medical Sciences Mashhad Iran'}]}],
'member': '311',
'published-online': {'date-parts': [[2021, 1, 3]]},
'reference': [ {'key': 'e_1_2_8_2_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/jcp.25778'},
{'key': 'e_1_2_8_3_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.6745'},
{'key': 'e_1_2_8_4_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.fct.2020.111699'},
{ 'key': 'e_1_2_8_5_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1371/journal.pone.0057285'},
{ 'key': 'e_1_2_8_6_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1371/journal.pone.0134982'},
{'key': 'e_1_2_8_7_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1089/ars.2005.7.32'},
{ 'key': 'e_1_2_8_8_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1111/j.1440-1681.2011.05648.x'},
{ 'issue': '3',
'key': 'e_1_2_8_9_1',
'first-page': '282',
'article-title': 'Novel nanomicelle formulation to enhance bioavailability and stability '
'of curcuminoids',
'volume': '22',
'author': 'Hatamipour M.',
'year': '2019',
'journal-title': 'Iranian Journal of Basic Medical Sciences'},
{ 'key': 'e_1_2_8_10_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1161/CIRCULATIONAHA.108.768986'},
{'key': 'e_1_2_8_11_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/1475-2891-13-11'},
{'key': 'e_1_2_8_12_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1089/ars.2008.2140'},
{ 'key': 'e_1_2_8_13_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.intimp.2013.01.003'},
{'key': 'e_1_2_8_14_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/apt.15916'},
{'key': 'e_1_2_8_15_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s12072-020-10071-9'},
{ 'key': 'e_1_2_8_16_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(20)30628-0'},
{'key': 'e_1_2_8_17_1', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules25030689'},
{ 'key': 'e_1_2_8_18_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1080/10408398.2017.1358139'},
{ 'key': 'e_1_2_8_19_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.antiviral.2017.03.014'},
{ 'key': 'e_1_2_8_20_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1021/acs.jmedchem.6b00975'},
{'key': 'e_1_2_8_21_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s10900-020-00920-x'},
{'key': 'e_1_2_8_22_1', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fmicb.2019.00912'},
{'key': 'e_1_2_8_23_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1039/C5FO00485C'},
{'key': 'e_1_2_8_24_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1152/ajpgi.90428.2008'},
{ 'key': 'e_1_2_8_25_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(20)30304-4'},
{ 'key': 'e_1_2_8_26_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/j.tmaid.2020.101623'},
{'key': 'e_1_2_8_27_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.6766'},
{'key': 'e_1_2_8_28_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00134-020-05991-x'},
{ 'key': 'e_1_2_8_29_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1097/CCM.0000000000001402'},
{'key': 'e_1_2_8_30_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1177/1074248413503044'},
{ 'key': 'e_1_2_8_31_1',
'first-page': '2020030214',
'article-title': 'Revealing the potency of citrus and galangal constituents to Halt '
'SARS‐CoV‐2 infection',
'author': 'Utomo R. Y.',
'year': '2020',
'journal-title': 'Preprints'},
{ 'key': 'e_1_2_8_32_1',
'doi-asserted-by': 'publisher',
'DOI': '10.1016/S0140-6736(20)30185-9'},
{'key': 'e_1_2_8_33_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1177/0962280215588241'},
{'key': 'e_1_2_8_34_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.6738'},
{'key': 'e_1_2_8_35_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1155/2014/186864'}],
'container-title': 'Phytotherapy Research',
'original-title': [],
'language': 'en',
'link': [ { 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7004',
'content-type': 'application/pdf',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ptr.7004',
'content-type': 'application/xml',
'content-version': 'vor',
'intended-application': 'text-mining'},
{ 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7004',
'content-type': 'unspecified',
'content-version': 'vor',
'intended-application': 'similarity-checking'}],
'deposited': { 'date-parts': [[2023, 9, 2]],
'date-time': '2023-09-02T02:27:24Z',
'timestamp': 1693621644000},
'score': 1,
'resource': {'primary': {'URL': 'https://onlinelibrary.wiley.com/doi/10.1002/ptr.7004'}},
'subtitle': [],
'short-title': [],
'issued': {'date-parts': [[2021, 1, 3]]},
'references-count': 34,
'journal-issue': {'issue': '5', 'published-print': {'date-parts': [[2021, 5]]}},
'alternative-id': ['10.1002/ptr.7004'],
'URL': 'http://dx.doi.org/10.1002/ptr.7004',
'relation': {},
'ISSN': ['0951-418X', '1099-1573'],
'subject': ['Pharmacology'],
'container-title-short': 'Phytotherapy Research',
'published': {'date-parts': [[2021, 1, 3]]},
'assertion': [ { 'value': '2020-08-18',
'order': 0,
'name': 'received',
'label': 'Received',
'group': {'name': 'publication_history', 'label': 'Publication History'}},
{ 'value': '2020-12-14',
'order': 1,
'name': 'accepted',
'label': 'Accepted',
'group': {'name': 'publication_history', 'label': 'Publication History'}},
{ 'value': '2021-01-03',
'order': 2,
'name': 'published',
'label': 'Published',
'group': {'name': 'publication_history', 'label': 'Publication History'}}]}
